Metraipolis › archive › dc_ff72d1070447
Updating the MASH pharmacotherapy landscape: a network meta-analysis incorporating SGLT2 inhibitors and emerging combination therapies — Europe PMC PMID:42325618
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42325618
- DOI
- 10.3389/fendo.2026.1829315
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-31T19:28:54.341Z
- SHA-256 of the archived text
3d424aaabdb0997dfece174b604915a364c75d1bd5bae437052d9bff5382211b- Stable URL of this page
https://metraipolis.com/documento/dc_ff72d1070447
How to cite
Updating the MASH pharmacotherapy landscape: a network meta-analysis incorporating SGLT2 inhibitors and emerging combination therapies — Europe PMC PMID:42325618 — Europe PMC (en), https://europepmc.org/article/MED/42325618 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ff72d1070447 (Metraipolis archive dc_ff72d1070447, sha256 3d424aaabdb0997dfece174b604915a364c75d1bd5bae437052d9bff5382211b)
BibTeX
@misc{dcff72d1070447,
title = {Updating the MASH pharmacotherapy landscape: a network meta-analysis incorporating SGLT2 inhibitors and emerging combination therapies — Europe PMC PMID:42325618},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42325618},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ff72d1070447; sha256 3d424aaabdb0997dfece174b604915a364c75d1bd5bae437052d9bff5382211b},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42325618. Agents can read the archived copy with the MCP tool read_document.